Drug details

Onivyde (irinotecan liposome injection)

type of Antineoplastic Topoisomerase Inhibitors, Antineoplastics Camptothecins

Onivyde (irinotecan liposome injection) is a topoisomerase inhibitor indicated, in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• fever,
• easy bruising,
• unusual bleeding,
• pale skin,
• lightheadedness,
• shortness of breath,
• cold hands and feet,
• confusion,
• chills,
• severe drowsiness,
• fast heartbeats,
• tiredness,
• wheezing,
• little or no urination,
• chest tightness,
• new or worsening cough,
• skin sores,
• feeling very thirsty or hot,
• black or bloody stools,
• heavy sweating,
• rapid breathing, and
• severe or ongoing vomiting or diarrhea,
• sores or white patches in or around your mouth,
• hot or dry skin,
• feeling very ill